Bionovo Publishes Discoveries In Predictable Tissue Selectivity For Selective Estrogen Receptor Modulators Platform
Bionovo, Inc. (Nasdaq: BNVI) announced results describing predictable estrogen regulatory elements that can be used to identify estrogenic drugs that are safer. The data, published in Molecular and Cellular Endocrinology, showed that the new regulatory elements can distinguish the estrogenic pharmacological activity exerted by different compounds and allow for more accurate prediction of specific tissue effect.
More: continued here
Filed under: Endocrinology on January 14th, 2009